Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030

Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030

Industry: Chemical & Material

Published Date: 2024-04-12

Pages: 113 Pages

Report ld: 2923403

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pharmaceutical Pregelatinized Starch Market Size(US$)

CAGR 2024-2030

4.4%

Market Size,2030

USD 2,304.7

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,780 million

Market Forecast in 2030(Value)

US$ 2,304.7 million

CAGR

4.4%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.

The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1780 million in 2024 to US$ 2304.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

In terms of production side, this report researches the Pharmaceutical Pregelatinized Starch production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Pharmaceutical Pregelatinized Starch by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for Pharmaceutical Pregelatinized Starch, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pharmaceutical Pregelatinized Starch, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Pregelatinized Starch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Pregelatinized Starch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Pregelatinized Starch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Pregelatinized Starch sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Signet
MIKEM
Nippon Starch Chemical Co.,Ltd.
Patel Chem Specialties Pvt Ltd
Roquette
SMS
Starch Asia
Universal Starch Chem Allied Ltd.
Cargill
Tate&Lyle
Visco Starch
Galam
Banpong Tapioca Flour Industrial
Crest Cellulose
DFE Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Fully Pregelatinized Starch
Partially Pregelatinized Starch

Segment by Application

Capsule
Tablet

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Pharmaceutical Pregelatinized Starch production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Pharmaceutical Pregelatinized Starch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Pregelatinized Starch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Pregelatinized Starch sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Pharmaceutical Pregelatinized Starch Product Introduction

1.2 Market by Type

1.2.1 Global Pharmaceutical Pregelatinized Starch Market Size by Type, 2019 VS 2023 VS 2030

1.2.2 Fully Pregelatinized Starch

1.2.3 Partially Pregelatinized Starch

1.3 Market by Application

1.3.1 Global Pharmaceutical Pregelatinized Starch Market Size by Application, 2019 VS 2023 VS 2030

1.3.2 Capsule

1.3.3 Tablet

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Pharmaceutical Pregelatinized Starch Production

2.1 Global Pharmaceutical Pregelatinized Starch Production Capacity (2019-2030)

2.2 Global Pharmaceutical Pregelatinized Starch Production by Region: 2019 VS 2023 VS 2030

2.3 Global Pharmaceutical Pregelatinized Starch Production by Region

2.3.1 Global Pharmaceutical Pregelatinized Starch Historic Production by Region (2019-2024)

2.3.2 Global Pharmaceutical Pregelatinized Starch Forecasted Production by Region (2025-2030)

2.3.3 Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2019-2030)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3 Executive Summary

3.1 Global Pharmaceutical Pregelatinized Starch Revenue Estimates and Forecasts 2019-2030

3.2 Global Pharmaceutical Pregelatinized Starch Revenue by Region

3.2.1 Global Pharmaceutical Pregelatinized Starch Revenue by Region: 2019 VS 2023 VS 2030

3.2.2 Global Pharmaceutical Pregelatinized Starch Revenue by Region (2019-2024)

3.2.3 Global Pharmaceutical Pregelatinized Starch Revenue by Region (2025-2030)

3.2.4 Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Region (2019-2030)

3.3 Global Pharmaceutical Pregelatinized Starch Sales Estimates and Forecasts 2019-2030

3.4 Global Pharmaceutical Pregelatinized Starch Sales by Region

3.4.1 Global Pharmaceutical Pregelatinized Starch Sales by Region: 2019 VS 2023 VS 2030

3.4.2 Global Pharmaceutical Pregelatinized Starch Sales by Region (2019-2024)

3.4.3 Global Pharmaceutical Pregelatinized Starch Sales by Region (2025-2030)

3.4.4 Global Pharmaceutical Pregelatinized Starch Sales Market Share by Region (2019-2030)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

4.1 Global Pharmaceutical Pregelatinized Starch Sales by Manufacturers

4.1.1 Global Pharmaceutical Pregelatinized Starch Sales by Manufacturers (2019-2024)

4.1.2 Global Pharmaceutical Pregelatinized Starch Sales Market Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharmaceutical Pregelatinized Starch in 2023

4.2 Global Pharmaceutical Pregelatinized Starch Revenue by Manufacturers

4.2.1 Global Pharmaceutical Pregelatinized Starch Revenue by Manufacturers (2019-2024)

4.2.2 Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Pregelatinized Starch Revenue in 2023

4.3 Global Pharmaceutical Pregelatinized Starch Sales Price by Manufacturers

4.4 Global Key Players of Pharmaceutical Pregelatinized Starch, Industry Ranking, 2022 VS 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Product Offered and Application

4.8 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Pharmaceutical Pregelatinized Starch Sales by Type

5.1.1 Global Pharmaceutical Pregelatinized Starch Historical Sales by Type (2019-2024)

5.1.2 Global Pharmaceutical Pregelatinized Starch Forecasted Sales by Type (2025-2030)

5.1.3 Global Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

5.2 Global Pharmaceutical Pregelatinized Starch Revenue by Type

5.2.1 Global Pharmaceutical Pregelatinized Starch Historical Revenue by Type (2019-2024)

5.2.2 Global Pharmaceutical Pregelatinized Starch Forecasted Revenue by Type (2025-2030)

5.2.3 Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

5.3 Global Pharmaceutical Pregelatinized Starch Price by Type

5.3.1 Global Pharmaceutical Pregelatinized Starch Price by Type (2019-2024)

5.3.2 Global Pharmaceutical Pregelatinized Starch Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global Pharmaceutical Pregelatinized Starch Sales by Application

6.1.1 Global Pharmaceutical Pregelatinized Starch Historical Sales by Application (2019-2024)

6.1.2 Global Pharmaceutical Pregelatinized Starch Forecasted Sales by Application (2025-2030)

6.1.3 Global Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

6.2 Global Pharmaceutical Pregelatinized Starch Revenue by Application

6.2.1 Global Pharmaceutical Pregelatinized Starch Historical Revenue by Application (2019-2024)

6.2.2 Global Pharmaceutical Pregelatinized Starch Forecasted Revenue by Application (2025-2030)

6.2.3 Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

6.3 Global Pharmaceutical Pregelatinized Starch Price by Application

6.3.1 Global Pharmaceutical Pregelatinized Starch Price by Application (2019-2024)

6.3.2 Global Pharmaceutical Pregelatinized Starch Price Forecast by Application (2025-2030)

7 US & Canada

7.1 US & Canada Pharmaceutical Pregelatinized Starch Market Size by Type

7.1.1 US & Canada Pharmaceutical Pregelatinized Starch Sales by Type (2019-2030)

7.1.2 US & Canada Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2030)

7.2 US & Canada Pharmaceutical Pregelatinized Starch Market Size by Application

7.2.1 US & Canada Pharmaceutical Pregelatinized Starch Sales by Application (2019-2030)

7.2.2 US & Canada Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2030)

7.3 US & Canada Pharmaceutical Pregelatinized Starch Sales by Country

7.3.1 US & Canada Pharmaceutical Pregelatinized Starch Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 US & Canada Pharmaceutical Pregelatinized Starch Sales by Country (2019-2030)

7.3.3 US & Canada Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2030)

7.3.4 United States

7.3.5 Canada

8 Europe

8.1 Europe Pharmaceutical Pregelatinized Starch Market Size by Type

8.1.1 Europe Pharmaceutical Pregelatinized Starch Sales by Type (2019-2030)

8.1.2 Europe Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2030)

8.2 Europe Pharmaceutical Pregelatinized Starch Market Size by Application

8.2.1 Europe Pharmaceutical Pregelatinized Starch Sales by Application (2019-2030)

8.2.2 Europe Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2030)

8.3 Europe Pharmaceutical Pregelatinized Starch Sales by Country

8.3.1 Europe Pharmaceutical Pregelatinized Starch Revenue by Country: 2019 VS 2023 VS 2030

8.3.2 Europe Pharmaceutical Pregelatinized Starch Sales by Country (2019-2030)

8.3.3 Europe Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2030)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China Pharmaceutical Pregelatinized Starch Market Size by Type

9.1.1 China Pharmaceutical Pregelatinized Starch Sales by Type (2019-2030)

9.1.2 China Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2030)

9.2 China Pharmaceutical Pregelatinized Starch Market Size by Application

9.2.1 China Pharmaceutical Pregelatinized Starch Sales by Application (2019-2030)

9.2.2 China Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2030)

10 Asia (excluding China)

10.1 Asia Pharmaceutical Pregelatinized Starch Market Size by Type

10.1.1 Asia Pharmaceutical Pregelatinized Starch Sales by Type (2019-2030)

10.1.2 Asia Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2030)

10.2 Asia Pharmaceutical Pregelatinized Starch Market Size by Application

10.2.1 Asia Pharmaceutical Pregelatinized Starch Sales by Application (2019-2030)

10.2.2 Asia Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2030)

10.3 Asia Pharmaceutical Pregelatinized Starch Sales by Region

10.3.1 Asia Pharmaceutical Pregelatinized Starch Revenue by Region: 2019 VS 2023 VS 2030

10.3.2 Asia Pharmaceutical Pregelatinized Starch Revenue by Region (2019-2030)

10.3.3 Asia Pharmaceutical Pregelatinized Starch Sales by Region (2019-2030)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Market Size by Type

11.1.1 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Type (2019-2030)

11.1.2 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2030)

11.2 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Market Size by Application

11.2.1 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Application (2019-2030)

11.2.2 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2030)

11.3 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Country

11.3.1 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Country: 2019 VS 2023 VS 2030

11.3.2 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2030)

11.3.3 Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Country (2019-2030)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profiles

12.1 Signet

12.1.1 Signet Company Information

12.1.2 Signet Overview

12.1.3 Signet Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.1.4 Signet Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Signet Recent Developments

12.2 MIKEM

12.2.1 MIKEM Company Information

12.2.2 MIKEM Overview

12.2.3 MIKEM Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.2.4 MIKEM Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 MIKEM Recent Developments

12.3 Nippon Starch Chemical Co.,Ltd.

12.3.1 Nippon Starch Chemical Co.,Ltd. Company Information

12.3.2 Nippon Starch Chemical Co.,Ltd. Overview

12.3.3 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.3.4 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Nippon Starch Chemical Co.,Ltd. Recent Developments

12.4 Patel Chem Specialties Pvt Ltd

12.4.1 Patel Chem Specialties Pvt Ltd Company Information

12.4.2 Patel Chem Specialties Pvt Ltd Overview

12.4.3 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.4.4 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Patel Chem Specialties Pvt Ltd Recent Developments

12.5 Roquette

12.5.1 Roquette Company Information

12.5.2 Roquette Overview

12.5.3 Roquette Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.5.4 Roquette Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Roquette Recent Developments

12.6 SMS

12.6.1 SMS Company Information

12.6.2 SMS Overview

12.6.3 SMS Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.6.4 SMS Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 SMS Recent Developments

12.7 Starch Asia

12.7.1 Starch Asia Company Information

12.7.2 Starch Asia Overview

12.7.3 Starch Asia Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.7.4 Starch Asia Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Starch Asia Recent Developments

12.8 Universal Starch Chem Allied Ltd.

12.8.1 Universal Starch Chem Allied Ltd. Company Information

12.8.2 Universal Starch Chem Allied Ltd. Overview

12.8.3 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.8.4 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Universal Starch Chem Allied Ltd. Recent Developments

12.9 Cargill

12.9.1 Cargill Company Information

12.9.2 Cargill Overview

12.9.3 Cargill Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.9.4 Cargill Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Cargill Recent Developments

12.10 Tate&Lyle

12.10.1 Tate&Lyle Company Information

12.10.2 Tate&Lyle Overview

12.10.3 Tate&Lyle Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.10.4 Tate&Lyle Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 Tate&Lyle Recent Developments

12.11 Visco Starch

12.11.1 Visco Starch Company Information

12.11.2 Visco Starch Overview

12.11.3 Visco Starch Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.11.4 Visco Starch Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 Visco Starch Recent Developments

12.12 Galam

12.12.1 Galam Company Information

12.12.2 Galam Overview

12.12.3 Galam Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.12.4 Galam Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.12.5 Galam Recent Developments

12.13 Banpong Tapioca Flour Industrial

12.13.1 Banpong Tapioca Flour Industrial Company Information

12.13.2 Banpong Tapioca Flour Industrial Overview

12.13.3 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.13.4 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.13.5 Banpong Tapioca Flour Industrial Recent Developments

12.14 Crest Cellulose

12.14.1 Crest Cellulose Company Information

12.14.2 Crest Cellulose Overview

12.14.3 Crest Cellulose Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.14.4 Crest Cellulose Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.14.5 Crest Cellulose Recent Developments

12.15 DFE Pharma

12.15.1 DFE Pharma Company Information

12.15.2 DFE Pharma Overview

12.15.3 DFE Pharma Pharmaceutical Pregelatinized Starch Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.15.4 DFE Pharma Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

12.15.5 DFE Pharma Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Pharmaceutical Pregelatinized Starch Industry Chain Analysis

13.2 Pharmaceutical Pregelatinized Starch Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Pharmaceutical Pregelatinized Starch Production Mode & Process

13.4 Pharmaceutical Pregelatinized Starch Sales and Marketing

13.4.1 Pharmaceutical Pregelatinized Starch Sales Channels

13.4.2 Pharmaceutical Pregelatinized Starch Distributors

13.5 Pharmaceutical Pregelatinized Starch Customers

14 Pharmaceutical Pregelatinized Starch Market Dynamics

14.1 Pharmaceutical Pregelatinized Starch Industry Trends

14.2 Pharmaceutical Pregelatinized Starch Market Drivers

14.3 Pharmaceutical Pregelatinized Starch Market Challenges

14.4 Pharmaceutical Pregelatinized Starch Market Restraints

15 Key Finding in The Global Pharmaceutical Pregelatinized Starch Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Pregelatinized Starch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Fully Pregelatinized Starch

Table 3. Major Manufacturers of Partially Pregelatinized Starch

Table 4. Global Pharmaceutical Pregelatinized Starch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pharmaceutical Pregelatinized Starch Production by Region: 2019 VS 2023 VS 2030 (K Tons)

Table 6. Global Pharmaceutical Pregelatinized Starch Production by Region (2019-2024) & (K Tons)

Table 7. Global Pharmaceutical Pregelatinized Starch Production by Region (2025-2030) & (K Tons)

Table 8. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2019-2024)

Table 9. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2025-2030)

Table 10. Global Pharmaceutical Pregelatinized Starch Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pharmaceutical Pregelatinized Starch Revenue by Region (2019-2024) & (US$ Million)

Table 12. Global Pharmaceutical Pregelatinized Starch Revenue by Region (2025-2030) & (US$ Million)

Table 13. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Region (2019-2024)

Table 14. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Region (2025-2030)

Table 15. Global Pharmaceutical Pregelatinized Starch Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Pharmaceutical Pregelatinized Starch Sales by Region (2019-2024) & (K Tons)

Table 17. Global Pharmaceutical Pregelatinized Starch Sales by Region (2025-2030) & (K Tons)

Table 18. Global Pharmaceutical Pregelatinized Starch Sales Market Share by Region (2019-2024)

Table 19. Global Pharmaceutical Pregelatinized Starch Sales Market Share by Region (2025-2030)

Table 20. Global Pharmaceutical Pregelatinized Starch Sales by Manufacturers (2019-2024) & (K Tons)

Table 21. Global Pharmaceutical Pregelatinized Starch Sales Share by Manufacturers (2019-2024)

Table 22. Global Pharmaceutical Pregelatinized Starch Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 23. Global Pharmaceutical Pregelatinized Starch Revenue Share by Manufacturers (2019-2024)

Table 24. Pharmaceutical Pregelatinized Starch Price by Manufacturers 2019-2024 (US$/Ton)

Table 25. Global Key Players of Pharmaceutical Pregelatinized Starch, Industry Ranking, 2022 VS 2023 VS 2024

Table 26. Global Pharmaceutical Pregelatinized Starch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Pharmaceutical Pregelatinized Starch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Pregelatinized Starch as of 2023)

Table 28. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Manufacturing Base Distribution and Headquarters

Table 29. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Product Offered and Application

Table 30. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 33. Global Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 34. Global Pharmaceutical Pregelatinized Starch Sales Share by Type (2019-2024)

Table 35. Global Pharmaceutical Pregelatinized Starch Sales Share by Type (2025-2030)

Table 36. Global Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 37. Global Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 38. Global Pharmaceutical Pregelatinized Starch Revenue Share by Type (2019-2024)

Table 39. Global Pharmaceutical Pregelatinized Starch Revenue Share by Type (2025-2030)

Table 40. Pharmaceutical Pregelatinized Starch Price by Type (2019-2024) & (US$/Ton)

Table 41. Global Pharmaceutical Pregelatinized Starch Price Forecast by Type (2025-2030) & (US$/Ton)

Table 42. Global Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 43. Global Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 44. Global Pharmaceutical Pregelatinized Starch Sales Share by Application (2019-2024)

Table 45. Global Pharmaceutical Pregelatinized Starch Sales Share by Application (2025-2030)

Table 46. Global Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 47. Global Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 48. Global Pharmaceutical Pregelatinized Starch Revenue Share by Application (2019-2024)

Table 49. Global Pharmaceutical Pregelatinized Starch Revenue Share by Application (2025-2030)

Table 50. Pharmaceutical Pregelatinized Starch Price by Application (2019-2024) & (US$/Ton)

Table 51. Global Pharmaceutical Pregelatinized Starch Price Forecast by Application (2025-2030) & (US$/Ton)

Table 52. US & Canada Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 53. US & Canada Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 54. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 55. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 56. US & Canada Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 57. US & Canada Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 58. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 59. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 60. US & Canada Pharmaceutical Pregelatinized Starch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 61. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2024) & (US$ Million)

Table 62. US & Canada Pharmaceutical Pregelatinized Starch Revenue by Country (2025-2030) & (US$ Million)

Table 63. US & Canada Pharmaceutical Pregelatinized Starch Sales by Country (2019-2024) & (K Tons)

Table 64. US & Canada Pharmaceutical Pregelatinized Starch Sales by Country (2025-2030) & (K Tons)

Table 65. Europe Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 66. Europe Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 67. Europe Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 68. Europe Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 69. Europe Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 70. Europe Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 71. Europe Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 72. Europe Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 73. Europe Pharmaceutical Pregelatinized Starch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 74. Europe Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2024) & (US$ Million)

Table 75. Europe Pharmaceutical Pregelatinized Starch Revenue by Country (2025-2030) & (US$ Million)

Table 76. Europe Pharmaceutical Pregelatinized Starch Sales by Country (2019-2024) & (K Tons)

Table 77. Europe Pharmaceutical Pregelatinized Starch Sales by Country (2025-2030) & (K Tons)

Table 78. China Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 79. China Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 80. China Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 81. China Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 82. China Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 83. China Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 84. China Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 85. China Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 86. Asia Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 87. Asia Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 88. Asia Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 89. Asia Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 90. Asia Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 91. Asia Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 92. Asia Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 93. Asia Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 94. Asia Pharmaceutical Pregelatinized Starch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 95. Asia Pharmaceutical Pregelatinized Starch Revenue by Region (2019-2024) & (US$ Million)

Table 96. Asia Pharmaceutical Pregelatinized Starch Revenue by Region (2025-2030) & (US$ Million)

Table 97. Asia Pharmaceutical Pregelatinized Starch Sales by Region (2019-2024) & (K Tons)

Table 98. Asia Pharmaceutical Pregelatinized Starch Sales by Region (2025-2030) & (K Tons)

Table 99. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Type (2019-2024) & (K Tons)

Table 100. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Type (2025-2030) & (K Tons)

Table 101. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Type (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Type (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Application (2019-2024) & (K Tons)

Table 104. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Application (2025-2030) & (K Tons)

Table 105. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Application (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Application (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 108. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Country (2019-2024) & (US$ Million)

Table 109. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue by Country (2025-2030) & (US$ Million)

Table 110. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Country (2019-2024) & (K Tons)

Table 111. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales by Country (2025-2030) & (K Tons)

Table 112. Signet Company Information

Table 113. Signet Description and Major Businesses

Table 114. Signet Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. Signet Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Signet Recent Development

Table 117. MIKEM Company Information

Table 118. MIKEM Description and Major Businesses

Table 119. MIKEM Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. MIKEM Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. MIKEM Recent Development

Table 122. Nippon Starch Chemical Co.,Ltd. Company Information

Table 123. Nippon Starch Chemical Co.,Ltd. Description and Major Businesses

Table 124. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 125. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Nippon Starch Chemical Co.,Ltd. Recent Development

Table 127. Patel Chem Specialties Pvt Ltd Company Information

Table 128. Patel Chem Specialties Pvt Ltd Description and Major Businesses

Table 129. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 130. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Patel Chem Specialties Pvt Ltd Recent Development

Table 132. Roquette Company Information

Table 133. Roquette Description and Major Businesses

Table 134. Roquette Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 135. Roquette Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Roquette Recent Development

Table 137. SMS Company Information

Table 138. SMS Description and Major Businesses

Table 139. SMS Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 140. SMS Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. SMS Recent Development

Table 142. Starch Asia Company Information

Table 143. Starch Asia Description and Major Businesses

Table 144. Starch Asia Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 145. Starch Asia Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Starch Asia Recent Development

Table 147. Universal Starch Chem Allied Ltd. Company Information

Table 148. Universal Starch Chem Allied Ltd. Description and Major Businesses

Table 149. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 150. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Universal Starch Chem Allied Ltd. Recent Development

Table 152. Cargill Company Information

Table 153. Cargill Description and Major Businesses

Table 154. Cargill Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 155. Cargill Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Cargill Recent Development

Table 157. Tate&Lyle Company Information

Table 158. Tate&Lyle Description and Major Businesses

Table 159. Tate&Lyle Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 160. Tate&Lyle Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Tate&Lyle Recent Development

Table 162. Visco Starch Company Information

Table 163. Visco Starch Description and Major Businesses

Table 164. Visco Starch Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 165. Visco Starch Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Visco Starch Recent Development

Table 167. Galam Company Information

Table 168. Galam Description and Major Businesses

Table 169. Galam Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 170. Galam Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Galam Recent Development

Table 172. Banpong Tapioca Flour Industrial Company Information

Table 173. Banpong Tapioca Flour Industrial Description and Major Businesses

Table 174. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 175. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Banpong Tapioca Flour Industrial Recent Development

Table 177. Crest Cellulose Company Information

Table 178. Crest Cellulose Description and Major Businesses

Table 179. Crest Cellulose Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 180. Crest Cellulose Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. Crest Cellulose Recent Development

Table 182. DFE Pharma Company Information

Table 183. DFE Pharma Description and Major Businesses

Table 184. DFE Pharma Pharmaceutical Pregelatinized Starch Capacity Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 185. DFE Pharma Pharmaceutical Pregelatinized Starch Product Model Numbers, Pictures, Descriptions and Specifications

Table 186. DFE Pharma Recent Development

Table 187. Key Raw Materials Lists

Table 188. Raw Materials Key Suppliers Lists

Table 189. Pharmaceutical Pregelatinized Starch Distributors List

Table 190. Pharmaceutical Pregelatinized Starch Customers List

Table 191. Pharmaceutical Pregelatinized Starch Market Trends

Table 192. Pharmaceutical Pregelatinized Starch Market Drivers

Table 193. Pharmaceutical Pregelatinized Starch Market Challenges

Table 194. Pharmaceutical Pregelatinized Starch Market Restraints

Table 195. Research Programs/Design for This Report

Table 196. Key Data Information from Secondary Sources

Table 197. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Pregelatinized Starch Product Picture

Figure 2. Global Pharmaceutical Pregelatinized Starch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pharmaceutical Pregelatinized Starch Market Share by Type in 2023 & 2030

Figure 4. Fully Pregelatinized Starch Product Picture

Figure 5. Partially Pregelatinized Starch Product Picture

Figure 6. Global Pharmaceutical Pregelatinized Starch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pharmaceutical Pregelatinized Starch Market Share by Application in 2023 & 2030

Figure 8. Capsule

Figure 9. Tablet

Figure 10. Pharmaceutical Pregelatinized Starch Report Years Considered

Figure 11. Global Pharmaceutical Pregelatinized Starch Capacity, Production and Utilization (2019-2030) & (K Tons)

Figure 12. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 13. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2019-2030)

Figure 14. Pharmaceutical Pregelatinized Starch Production Growth Rate in North America (2019-2030) & (K Tons)

Figure 15. Pharmaceutical Pregelatinized Starch Production Growth Rate in Europe (2019-2030) & (K Tons)

Figure 16. Pharmaceutical Pregelatinized Starch Production Growth Rate in China (2019-2030) & (K Tons)

Figure 17. Pharmaceutical Pregelatinized Starch Production Growth Rate in Japan (2019-2030) & (K Tons)

Figure 18. Global Pharmaceutical Pregelatinized Starch Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Pharmaceutical Pregelatinized Starch Revenue 2019-2030 (US$ Million)

Figure 20. Global Pharmaceutical Pregelatinized Starch Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 21. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 22. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Region (2019-2030)

Figure 23. Global Pharmaceutical Pregelatinized Starch Sales 2019-2030 ((K Tons)

Figure 24. Global Pharmaceutical Pregelatinized Starch Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Tons)

Figure 25. Global Pharmaceutical Pregelatinized Starch Sales Market Share by Region (2019-2030)

Figure 26. US & Canada Pharmaceutical Pregelatinized Starch Sales YoY (2019-2030) & (K Tons)

Figure 27. US & Canada Pharmaceutical Pregelatinized Starch Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Europe Pharmaceutical Pregelatinized Starch Sales YoY (2019-2030) & (K Tons)

Figure 29. Europe Pharmaceutical Pregelatinized Starch Revenue YoY (2019-2030) & (US$ Million)

Figure 30. China Pharmaceutical Pregelatinized Starch Sales YoY (2019-2030) & (K Tons)

Figure 31. China Pharmaceutical Pregelatinized Starch Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Asia (excluding China) Pharmaceutical Pregelatinized Starch Sales YoY (2019-2030) & (K Tons)

Figure 33. Asia (excluding China) Pharmaceutical Pregelatinized Starch Revenue YoY (2019-2030) & (US$ Million)

Figure 34. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales YoY (2019-2030) & (K Tons)

Figure 35. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue YoY (2019-2030) & (US$ Million)

Figure 36. The Pharmaceutical Pregelatinized Starch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 37. The Top 5 and 10 Largest Manufacturers of Pharmaceutical Pregelatinized Starch in the World: Market Share by Pharmaceutical Pregelatinized Starch Revenue in 2023

Figure 38. Global Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 39. Global Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 40. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 41. Global Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 42. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 44. US & Canada Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 45. US & Canada Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 46. US & Canada Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 47. US & Canada Pharmaceutical Pregelatinized Starch Revenue Share by Country (2019-2030)

Figure 48. US & Canada Pharmaceutical Pregelatinized Starch Sales Share by Country (2019-2030)

Figure 49. U.S. Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 50. Canada Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 51. Europe Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 52. Europe Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 53. Europe Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 54. Europe Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 55. Europe Pharmaceutical Pregelatinized Starch Revenue Share by Country (2019-2030)

Figure 56. Europe Pharmaceutical Pregelatinized Starch Sales Share by Country (2019-2030)

Figure 57. Germany Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 58. France Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 59. U.K. Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 60. Italy Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 61. Russia Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 62. China Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 63. China Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 64. China Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 65. China Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 66. Asia Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 67. Asia Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 68. Asia Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 69. Asia Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 70. Asia Pharmaceutical Pregelatinized Starch Revenue Share by Region (2019-2030)

Figure 71. Asia Pharmaceutical Pregelatinized Starch Sales Share by Region (2019-2030)

Figure 72. Japan Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 73. South Korea Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 74. China Taiwan Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 75. Southeast Asia Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 76. India Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 77. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Revenue Share by Country (2019-2030)

Figure 82. Middle East, Africa and Latin America Pharmaceutical Pregelatinized Starch Sales Share by Country (2019-2030)

Figure 83. Brazil Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 84. Mexico Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 85. Turkey Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 86. Israel Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 87. GCC Countries Pharmaceutical Pregelatinized Starch Revenue (2019-2030) & (US$ Million)

Figure 88. Pharmaceutical Pregelatinized Starch Value Chain

Figure 89. Pharmaceutical Pregelatinized Starch Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Pharmaceutical Pregelatinized Starch market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Pharmaceutical Pregelatinized Starch market is 4.4% 2024 to 2030.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Pharmaceutical Pregelatinized Starch market? shouQi

What was the global market size of Pharmaceutical Pregelatinized Starch in 2024? shouQi

What was the global market size of Pharmaceutical Pregelatinized Starch in 2030? shouQi

Related Reports

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2026
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1924 million in 2025 and is anticipated to reach US$ 2590 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 95
USD 4250.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 152
USD 4900.00
(Single User License)
Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published Date: 2024-01-17
Pages: 119
USD 2900.00
(Single User License)

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2026
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1924 million in 2025 and is anticipated to reach US$ 2590 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-04-18
Pages: 136
USD 2900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 95
USD 4250.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 152
USD 4900.00 (Single User License)
Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 117
USD 3950.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-01-16
Pages: 104
USD 2900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published: 2024-01-17
Pages: 119
USD 2900.00 (Single User License)